Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain zaps show promise for paralyzed arms – but study cut short

NCT ID NCT05390853

Symptom relief Sponsor: Montecatone Rehabilitation Institute S.p.A. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a non-invasive brain stimulation method called tDCS, when added to standard physical therapy, could improve arm and hand function in people with recent spinal cord injuries. The trial included 13 participants with neck-level injuries who were between 3 and 6 months post-injury. The study was terminated early, so results are limited, but the goal was to see if this approach is feasible and effective for enhancing recovery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

13 people

The number who actually took part.

Started

May 2023

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 74 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Traumatic SCI; * SCI neurological level, according to the American Spinal Injury Association (ASIA) definitions, from C3 to C7, included; * incomplete SCI (i.e. ASIA Impairment Scale: B, C or D); * distance from the SCI event: from 3 to 6 months; * residual motor ability of the target upper limb; * stable clinical conditions; * tolerance to sitting position for at least 45 minutes; * subjects capable and collaborating, able to give informed consent in person. Exclusion Criteria: * presence of implanted devices (e.g. pacemakers, intrathecal infusers, neurostimulators, hearing aids); * positive history of brain lesions; * presence of cerebral metallic implants (clips) or intracranial implants (e.g. ventriculoperitoneal shunt); * history of epilepsy or previous state of epileptic disease; * mechanical ventilation in place; * history of psychotic disorders; * history of severe neurodegenerative disease; * concomitant pre-existing clinical conditions that may interfere with movements of the target arm or hand (e.g. severe osteoarthritis, joint injuries, plexus injuries, peripheral nerve injuries, partial amputations); * use of antiepileptic drugs blocking Sodium o Calcium channels (e.g. Carbamazepine) or N-Methyl-D-Aspartate receptor antagonists (e.g. Dextromethorphan); * history of drugs abuse; * further contraindications to the use of TMS for PEMs elicitation (e.g. migraine with aura, permanent head / face tattoos); * presence of brain tumor; * pregnancy in progress.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Spinal cord injury cervical are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Spinal cord injury cervical

Contacts and locations

Locations

  • Montecatone Rehabilitation Institute S.p.A.

    Imola, BO, 40026, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.